BioNTech shares closed over 8% in trading Friday after announcing positive Phase 3 trial results for a breast cancer drug developed with Duality Biologics.
#BNTX #BioNTech #BNTXStock #BNTXNews #BNTXStockNews #BioNTechStock #BioNTechNews #BioNTechStockNews #DualityBio #BreastCancer #CancerResearch